INTRANASAL ADMINISTRATION OF MC4-R AGONISTS

Details for Australian Patent Application No. 2003219914 (hide)

Owner CHIRON CORPORATION

Inventors TOZZO, Effie; DUHL, David; XIAO, Linda, Li; XU, Baoji; LUO, Jian; JOHNSON, Kirk; FREY, William, H., II

Pub. Number AU-A-2003219914

PCT Number PCT/US03/05874

PCT Pub. Number WO2003/072056

Priority 60/358,700 25.02.02 US; 60/372,921 16.04.02 US

Filing date 25 February 2003

Wipo publication date 9 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/358,700 25.02.02 US; 60/372,921 16.04.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-A-2003219914

18 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219915-System and method for building and manipulating a centralized measurement value database

2003219913-PROPARGYLAMINO INDAN DERIVATIVES AND PROPARGYLAMINO TETRALIN DERIVATIVES AS BRAINSELECTIVE MAO INHIBITORS